Division of Pediatric Oncology, Department of Oncology, Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Blood. 2011 Dec 22;118(26):6943-51. doi: 10.1182/blood-2011-08-375170. Epub 2011 Nov 1.
Diamond-Blackfan anemia (DBA) is a congenital BM failure syndrome characterized by hypoproliferative anemia, associated physical abnormalities, and a predisposition to cancer. Perturbations of the ribosome appear to be critically important in DBA; alterations in 9 different ribosomal protein genes have been identified in multiple unrelated families, along with rarer abnormalities of additional ribosomal proteins. However, at present, only 50% to 60% of patients have an identifiable genetic lesion by ribosomal protein gene sequencing. Using genome-wide single-nucleotide polymorphism array to evaluate for regions of recurrent copy variation, we identified deletions at known DBA-related ribosomal protein gene loci in 17% (9 of 51) of patients without an identifiable mutation, including RPS19, RPS17, RPS26, and RPL35A. No recurrent regions of copy variation at novel loci were identified. Because RPS17 is a duplicated gene with 4 copies in a diploid genome, we demonstrate haploinsufficient RPS17 expression and a small subunit ribosomal RNA processing abnormality in patients harboring RPS17 deletions. Finally, we report the novel identification of variable mosaic loss involving known DBA gene regions in 3 patients from 2 kindreds. These data suggest that ribosomal protein gene deletion is more common than previously suspected and should be considered a component of the initial genetic evaluation in cases of suspected DBA.
Diamond-Blackfan 贫血(DBA)是一种先天性骨髓衰竭综合征,其特征为增生不良性贫血、相关的体格异常和癌症易感性。核糖体的改变似乎在 DBA 中非常重要;在多个不相关的家族中已经确定了 9 种不同的核糖体蛋白基因的改变,以及更罕见的其他核糖体蛋白的异常。然而,目前,通过核糖体蛋白基因测序,只有 50%至 60%的患者可识别出可识别的遗传病变。使用全基因组单核苷酸多态性微阵列评估反复出现的拷贝数变异区域,我们在 17%(51 例中 9 例)无可识别突变的患者中发现了已知与 DBA 相关的核糖体蛋白基因座的缺失,包括 RPS19、RPS17、RPS26 和 RPL35A。未发现新基因座的拷贝数变异的反复出现区域。由于 RPS17 是一个具有 4 个拷贝的二倍体基因组中的重复基因,我们证明了携带 RPS17 缺失的患者存在 RPS17 表达不足和小核糖体 RNA 处理异常。最后,我们报告了 3 名来自 2 个家系的患者中涉及已知 DBA 基因区域的可变镶嵌性缺失的新发现。这些数据表明,核糖体蛋白基因缺失比以前认为的更为常见,并且在怀疑 DBA 的情况下,应将其视为初始遗传评估的一部分。